
The new HEDIS diabetes blood pressure measure may promote performance incentives for overtreatment of blood pressure, causing potential harm, especially in the elderly population.
The new HEDIS diabetes blood pressure measure may promote performance incentives for overtreatment of blood pressure, causing potential harm, especially in the elderly population.
This report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.
Published: June 1st 2007 | Updated:
Published: January 14th 2010 | Updated:
Published: April 2nd 2009 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.